ModMed Secures Growth Investment from Clearlake Capital

What You Should Know:  – ModMed, a provider of specialty-specific healthcare SaaS technology, today announced a significant growth investment from Clearlake Capital Group, L.P.  – The investment will support ModMed’s continued innovation and expansion of its AI-powered solutions, empowering medical practices to enhance efficiency, improve patient experiences, and achieve sustainable growth. AI-Powered Solutions for Medical ... Read More

Mar 4, 2025 - 03:12
 0
ModMed Secures Growth Investment from Clearlake Capital

What You Should Know: 

ModMed, a provider of specialty-specific healthcare SaaS technology, today announced a significant growth investment from Clearlake Capital Group, L.P

– The investment will support ModMed’s continued innovation and expansion of its AI-powered solutions, empowering medical practices to enhance efficiency, improve patient experiences, and achieve sustainable growth.

AI-Powered Solutions for Medical Practices

ModMed offers a comprehensive suite of solutions designed to streamline clinical and operational workflows for medical practices across various specialties. The company’s technology leverages advanced AI and data analytics to automate tasks, improve decision-making, and enhance patient engagement.

ModMed’s solutions empower medical practices to:

  • Improve clinical efficiency: Streamline workflows and automate tasks to free up clinicians’ time for patient care.
  • Enhance patient experience: Deliver a more personalized and convenient experience for patients through digital tools and enhanced communication.
  • Optimize revenue cycle management: Improve billing accuracy, accelerate payments, and enhance financial performance.
  • Drive growth: Expand services, attract new patients, and achieve sustainable growth.

“For fifteen years, ModMed has operated with a clear and consistent mission: to place doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Since then, we have remained steadfast in our dedication to innovation and improving providers’ lives. Our journey with Warburg Pincus enabled us to scale and achieve significant milestones, and we look forward to our next chapter of growth with Clearlake and continuing to leverage technology to transform the patient-provider experience,” said Dan Cane, Co-Chief Executive Officer and Co-Founder, and Dr. Michael Sherling, Chief Medical and Strategy Officer and Co-Founder, at ModMed.